John Hubbard, PhD, FCP


John brings more than 30 years of leadership experience in the biopharmaceutical industry to guide Signant Health on its mission to transform the clinical trial process by providing simple, intuitive technologies that accelerate the clinical trial process, improve clinical data quality and enhance the lives of patients around the world.

Most recently, he was President and CEO of Bioclinica, a leading provider of medical imaging and clinical technologies.  Prior to Bioclinica, he was Senior Vice President and Worldwide Head of Development Operations at Pfizer.  He was responsible for global drug development of more than 450 clinical trials. Before joining Pfizer, he was Group President of ICON plc’s Global Clinical Research Division and also held executive positions at Parexel International Corporation and Sanofi Pharmaceuticals (formerly Hoechst Marion Roussel).

John was a founding member of the Board of Directors of TransCelerate Biopharma, Inc., is an Executive Committee Member Emeritus on the Clinical Trials Transformation Initiative (CTTI).  He is on the board of Agile Therapeutics (NASDAQ: AGRX), Life Sciences Pennsylvania, and was former Chairman of the Board of the Association of Clinical Research Organizations (ACRO).  As part of his role as a Healthcare Strategic Advisory Board Member to Genstar Capital, John advises the firm on healthcare investments and serves as a board member on portfolio companies (Signant Health and Advara). He was recognized by Pharma Voice as one of the 100 Most Inspirational People of 2016.

John’s Ph.D., is in cardiovascular physiology and he is a Fellow in the American College of Clinical Pharmacology.  His hobby is martial arts and holds a 4th Degree Black Belt and is a Master Instructor in Kung Jung Mu Sul.  John and his wife have been married 40 years, enjoy traveling globally and reside in Doylestown, Pennsylvania.